Ironwood Pharmaceuticals entered into a definitive agreement to acquire VectivBio for an estimated aggregate consideration of approximately $1 billion. Citibank, Citizens Bank, JPMorgan Chase, Royal Bank of Canada and Wells Fargo provided financing for the transaction.